The antiviral drug Paxlovid reduces the risk of getting long COVID

The antiviral medication Paxlovid seems to reduce the chance of developing long COVID, researchers report.

In a large study of veterans’ medical records, Paxlovid lowered a person’s chance of landing in the hospital or dying from all causes in the six months following a COVID-19 infection. And the drug reduced the risk of developing 10 of 13 long-term health problems, researchers report March 23 in JAMA Internal Medicine. On average, the drug lowered the relative risk of developing the conditions by 26 percent, says Ziyad Al-Aly, a clinical epidemiologist at Washington University School of Medicine in St. Louis.

The antiviral drug provided protection against some heart problems, blood clots,

→ Continue reading at Science News

More from author

Related posts

Advertisment

Latest posts

Charlie Munger mourned in China, where he said his best investment was made | CNN Business

Hong Kong CNN  —  Chinese social media users are mourning the death of billionaire investor Charlie Munger. ...

Video: Charlie Munger dead at 99 | CNN Business

Charlie Munger dead at 99 Link Copied! ...

9 Out-of-the-Box Side Hustles to Try in 2023

Since 2018, I've celebrated the holiday with an annual roundup of some of the most creative, outside-the-box side hustle ideas and stories that have...